9 Results for "

CDC25-IN-2

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "CDC25-IN-2" in MCE Product Catalog:

Cat. No.: HY-28086
CAS No.: 116452-88-1
Target:  

Phosphatase

Research Areas:  

Cancer

CDC25-IN-2 (Compound 1d) is a selective phosphatase Cdc25 inhibitor with IC50 values of 44.4, 55.2 and 53.9 μM for human Cdc25A, Cdc25B, Cdc25C. CDC25-IN-2 can block the cell cycle progression by inhibiting the activity of Cdc25 phosphatase. CDC25-IN-2 can be used for the research of cancer .
loading...
    loading...
6
6 Publications Verification
Cat. No.: HY-100034
CAS No.: 383907-43-5
Purity:  99.29%
Synonyms: DA-3003-1
Research Areas:  

Cancer

NSC 663284 (DA-3003-1) is a potent, cell-permeable, and irreversible Cdc25 dual specificity phosphatase inhibitor, has an IC50 for Cdc25B2 of 0.21 μM. NSC 663284 exhibits mixed competitive kinetics against Cdc25A, Cdc25B(2), and Cdc25C with Ki values of 29, 95, and 89 nM, respectively . NSC 663284 inhibits NSD2 (IC50 of 170 nM) through a direct interaction with the catalytic SET domain (Kd of 370 nM) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-112776A
CAS No.: 1049740-43-3
Purity:  99.36%
Target:  

Phosphatase

Research Areas:  

Cancer

BN82002 hydrochloride is a potent, selective and irreversible inhibitor of CDC25 phosphatase family. BN82002 hydrochloride inhibits CDC25A, CDC25B2, CDC25B3, CDC25C CDC25A, and 25C-cat with IC50 values of 2.4, 3.9, 6.3, 5.4, and 4.6 µM, respectively. BN82002 hydrochloride displays ~20-fold greater selectivity over CD45 tyrosine phosphatase .
loading...
    loading...
Cat. No.: HY-112776
CAS No.: 396073-89-5
Target:  

Phosphatase

Research Areas:  

Cancer

BN82002 is a potent, selective and irreversible inhibitor of CDC25 phosphatase family. BN82002 inhibits CDC25A, CDC25B2, CDC25B3, CDC25C CDC25A, and 25C-cat with IC50 values of 2.4, 3.9, 6.3, 5.4, and 4.6 µM, respectively. BN82002 displays ~20-fold greater selectivity over CD45 tyrosine phosphatase .
loading...
    loading...
Cat. No.: HY-121065
CAS No.: 477603-18-2
Purity:  ≥95.0%
Synonyms: IRC-083065
Target:  

Phosphatase

Research Areas:  

Cancer

BN-82685 is a a quinone-based CDC25 inhibitor with IC50 of 201 nM, 117 nM, 109 nM, 160 nM, 249 nM, for CDC25C, CDC25C-cat, CDC25A, CDC25B2, CDC25B3, respectively. BN-82685 plays an important role in cancer research .
loading...
    loading...
Cat. No.: HY-W102931
CAS No.: 6541-19-1
Target:  

Phosphatase

Research Areas:  

Cancer

6,7-Dichloroquinoline-5,8-dione (compound DA3002) is a potent CDC25B2 inhibitor with an IC50 value of 4.6 µM. 6,7-Dichloroquinoline-5,8-dione has the potential for the research of cancer .
loading...
    loading...
Cat. No.: HY-137175A
CAS No.: 134271-74-2
Purity:  97.02%
Target:  

Phosphatase

Research Areas:  

Cancer

CDC25B-IN-2 is a potent cdc25B inhibitor .
loading...
    loading...
Cat. No.: HY-100034R
CAS No.: 383907-43-5
Synonyms: DA-3003-1 (Standard)
NSC 663284 (Standard) is the analytical standard of NSC 663284 (HY-100034). This product is intended for research and analytical applications. NSC 663284 (DA-3003-1) is a potent, cell-permeable, and irreversible Cdc25 dual specificity phosphatase inhibitor, has an IC50 for Cdc25B2 of 0.21 μM. NSC 663284 exhibits mixed competitive kinetics against Cdc25A, Cdc25B(2), and Cdc25C with Ki values of 29, 95, and 89 nM, respectively . NSC 663284 inhibits NSD2 (IC50 of 170 nM) through a direct interaction with the catalytic SET domain (Kd of 370 nM) .
loading...
    loading...
Cat. No.: HY-180190
Research Areas:  

Cancer

Tubulin polymerization-IN-85 (Compound C21) is a tubulin polymerization inhibitor (IC50 = 1.59 μM) targeting the colchicine binding site. Tubulin polymerization-IN-85 can cause cancer cells G2/M phase arrest and induce apoptosis. Tubulin polymerization-IN-85 downregulates the expression of Bcl-2, Bcl-xl, Mcl-1, Cyclin B1, cdc25, cdc2 protein and upregulates P53, P21, Bad and Bax levels. Tubulin polymerization-IN-85 can be used for the research of cancer, such as cervical cancer .
loading...
    loading...